HistoSonics is a medical device and robotics company specializing in radiology and non-invasive surgical technology. With a mission to bring meaningful change to the lives of patients with non-invasive surgery, the company aims to use advanced scientific techniques of histotripsy in medical facilities across the globe. HistoSonics was founded by Brian Fowlkes, M. Christine Gibbons, and Thomas Davison in 2009 and is headquartered in Plymouth, Minnesota.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/15/2024 | Series D-1 | $102.7MM | $xx.xx | $598.27MM | Alpha Wave Ventures, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board | |
Price per Share
$xx.xx
Shares Outstanding
64,376,608
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Alpha Wave Ventures, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board
|
||||||
12/12/2022 | Series D-2 | $85MM | $xx.xx | $487.79MM | Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board | |
Price per Share
$xx.xx
Shares Outstanding
59,200,446
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board
|
||||||
04/15/2020 | Series C-1 | $40.76MM | $xx.xx | $279.68MM | Yonjin Venture, Varian Medical Systems, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, State of Wisconsin Investment Board | |
Price per Share
$xx.xx
Shares Outstanding
42,828,469
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Yonjin Venture, Varian Medical Systems, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, State of Wisconsin Investment Board
|
||||||
04/05/2019 | Series C | $54MM | $xx.xx | $222.19MM | Varian Medical Systems, Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, State of Wisconsin Investment Board, Frederic Moll | |
Price per Share
$xx.xx
Shares Outstanding
82,493,126
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
7.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Varian Medical Systems, Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, State of Wisconsin Investment Board, Frederic Moll
|
||||||
03/13/2017 | Series B | $12.09MM | $xx.xx | $66.08MM | Venture Investors, Hatteras Venture Partners, Fletcher Spaght Ventures, Early Stage Partners, TGap Ventures, UM-MINTS, Grand Angels, Wolverine Venture Fund | |
Price per Share
$xx.xx
Shares Outstanding
22,134,273
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Venture Investors, Hatteras Venture Partners, Fletcher Spaght Ventures, Early Stage Partners, TGap Ventures, UM-MINTS, Grand Angels, Wolverine Venture Fund
|
||||||
12/16/2009 | Series A | $14.17MM | $xx.xx | $56.69MM | Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners, TGap Ventures | |
Price per Share
$xx.xx
Shares Outstanding
14,172,418
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners, TGap Ventures
|